137 related articles for article (PubMed ID: 20939461)
1. Conflicts of interest within the French regulatory agency: more progress needed.
Prescrire Int; 2010 Aug; 19(108):186-8. PubMed ID: 20939461
[TBL] [Abstract][Full Text] [Related]
2. Recognising expertise would help to attract independent experts.
Prescrire Int; 2010 Aug; 19(108):187. PubMed ID: 20939462
[No Abstract] [Full Text] [Related]
3. Probity gone nuts.
Nat Biotechnol; 2007 May; 25(5):483. PubMed ID: 17483818
[TBL] [Abstract][Full Text] [Related]
4. A turning point for conflicts of interest: the controversy over the National Academy of Sciences' first conflicts of interest disclosure policy.
Parascandola M
J Clin Oncol; 2007 Aug; 25(24):3774-9. PubMed ID: 17704427
[TBL] [Abstract][Full Text] [Related]
5. [Disclosure of conflicts of interest in the Tijdschrift voor Psychiatrie].
Bergoets M; Pieters G
Tijdschr Psychiatr; 2009; 51(12):893-7. PubMed ID: 20047169
[TBL] [Abstract][Full Text] [Related]
6. Letting the sunshine in: shining a new light on physician-industry relationships.
Bruguera CM; Hirsch JA
J Neurointerv Surg; 2010 Mar; 2(1):80-2. PubMed ID: 21990565
[TBL] [Abstract][Full Text] [Related]
7. French law to make conflict of interest disclosure mandatory.
Louët S
Nat Med; 2011 Sep; 17(9):1026. PubMed ID: 21900902
[No Abstract] [Full Text] [Related]
8. Pharmaceuticals and medical devices: business practices. End-of-year issue brief.
Jones TM
Issue Brief Health Policy Track Serv; 2008 Jan; ():1-32. PubMed ID: 18345554
[No Abstract] [Full Text] [Related]
9. Plan to force drug companies in France to reveal payments to doctors has been diluted, campaigners say.
Benkimoun P
BMJ; 2012 Dec; 345():e8405. PubMed ID: 23236045
[No Abstract] [Full Text] [Related]
10. French "sunshine act" sheds little light on drug industry's payments to doctors, say critics.
Benkimoun P
BMJ; 2013 Jun; 346():f3762. PubMed ID: 23757751
[No Abstract] [Full Text] [Related]
11. Advisory committees at FDA: the Hinchey Amendment and "conflict of interest" waivers.
Lietzan E
J Health Law; 2006; 39(4):415-49. PubMed ID: 17402656
[TBL] [Abstract][Full Text] [Related]
12. The long arm of financial conflicts of interest: extensions into lined pockets, research and review, and the United States Senate.
Rivkees SA
J Pediatr Endocrinol Metab; 2008 Jul; 21(7):607-9. PubMed ID: 18780592
[No Abstract] [Full Text] [Related]
13. Conflicts of interest in medical research: how much conflict should exceed legal boundaries?
Klanica K
J Biolaw Bus; 2005; 8(3):37-45. PubMed ID: 16459426
[TBL] [Abstract][Full Text] [Related]
14. Transparency urged over research payments.
Check E
Nature; 2007 Aug; 448(7155):738. PubMed ID: 17700667
[No Abstract] [Full Text] [Related]
15. [Disclosure of conflicts of interest in hospital pharmacy posters in France: we still have a long way to go].
Édouard B; Toth K; Descout J
Ann Pharm Fr; 2013 May; 71(3):159-63. PubMed ID: 23622694
[TBL] [Abstract][Full Text] [Related]
16. Conflicts of interest and disclosure in the American Psychiatric Association's Clinical Practice Guidelines.
Cosgrove L; Bursztajn HJ; Krimsky S; Anaya M; Walker J
Psychother Psychosom; 2009; 78(4):228-32. PubMed ID: 19401623
[TBL] [Abstract][Full Text] [Related]
17. Commentary: Disclosure's failings: what is the alternative?
Kassirer JP
Acad Med; 2009 Sep; 84(9):1180-1. PubMed ID: 19707054
[TBL] [Abstract][Full Text] [Related]
18. The corporate coauthor.
Fugh-Berman A
J Gen Intern Med; 2005 Jun; 20(6):546-8. PubMed ID: 15987332
[TBL] [Abstract][Full Text] [Related]
19. Doctors and drug companies--scrutinizing influential relationships.
Campbell EG
N Engl J Med; 2007 Nov; 357(18):1796-7. PubMed ID: 17978288
[No Abstract] [Full Text] [Related]
20. Financial conflicts of interest in human subjects research: proposals for a more effective regulatory scheme.
Jordan KA
Wash Lee Law Rev; 2003; 60(1):15-109. PubMed ID: 16273696
[No Abstract] [Full Text] [Related]
[Next] [New Search]
